News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis B news

Show

From To
Injecting drug users
WHO: Four ways to reduce hepatitis infections in people who inject drugs

WHO has identified four key actions countries can take to prevent viral hepatitis B and C among people who inject drugs. Of the estimated 16 million people who inject drugs worldwide, it is estimated that 10 million are infected with hepatitis C. An additional 1.2 million are infected with hepatitis B.

Published
21 July 2012
From
World Health Organization
Hepatitis B
Hepatitis B vaccine protects for 25 years: study

Vaccination against hepatitis B seems to protect against the virus for 25 years, suggesting booster shots are unnecessary, according to a new study from Taiwan.

Published
21 June 2012
From
Reuters
Hepatitis C symptoms and diagnosis
NICE consults on new public health guidance aiming to improve uptake of testing for hepatitis B and C

Ignorance about the risk factors and causes of hepatitis B and C, and misconceptions about its treatment need to be tackled if barriers to effective testing of those at increased risk of infection are to be overcome, according to draft guidance issued by NICE.

Published
18 June 2012
From
NICE press release
Hepatitis B
Hepatitis B is a major health issue for migrants in the US

Between 1.04 million and 1.61 million migrants now resident in the US have chronic hepatitis B infection, investigators report in the online edition of Hepatology.  “The

Published
07 June 2012
By
Michael Carter
Cancer
Four Bad Actors Cause Most Infection-Related Cancer

Three types of viruses and 1 bacterium cause the vast majority of the new cases of cancer worldwide that are attributable to infections, according to a new study of global data.

Published
11 May 2012
From
Medscape (requires registration)
Cancer
Brivanib did not improve overall liver cancer survival, but did show anti-tumour activity

The experimental cancer drug brivanib did not lengthen overall survival for patients with hepatocellular carcinoma, but it did increase time to progression, demonstrating that it had anti-tumour

Published
30 April 2012
By
Liz Highleyman
Outcomes and prognosis
Chronic hepatitis B infection associated with twice the risk of liver-related death compared to hepatitis C

The risk of death due to liver disease is twice as high for patients with chronic hepatitis B infection compared to individuals with chronic hepatitis C, US

Published
27 April 2012
By
Michael Carter
Hepatitis B
Telbivudine cuts mother-to-infant hepatitis B transmission

Telbivudine taken during the second or third trimester of pregnancy reduced the mother-to-infant transmission of hepatitis B to zero in an open-label trial of 88 women who had high viral loads and elevated alanine aminotransferase levels, Dr. Calvin Q. Pan and his colleagues reported in the May issue of Clinical Gastroenterology and Hepatology.

Published
16 April 2012
From
Family Practice News
Hepatitis C treatment
Antiretroviral rollout provides a model for efforts to expand hepatitis C treatment and care in resource-limited settings

The rollout of antiretroviral therapy in resource-limited settings provides a model for efforts to increase access to hepatitis C treatment and care in similar settings, investigators argue

Published
27 March 2012
By
Michael Carter
Hepatitis C symptoms and diagnosis
Hepatitis C surpasses HIV as a cause of death in the US

Deaths in the US due to hepatitis C now exceed those caused by HIV, according to research published in the Annals of Internal Medicine.  The study

Published
21 February 2012
By
Michael Carter
← Prev1...23456...7Next →

Filter by country